These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 23541585)
1. Nuclear localization of CPI-17, a protein phosphatase-1 inhibitor protein, affects histone H3 phosphorylation and corresponds to proliferation of cancer and smooth muscle cells. Eto M; Kirkbride JA; Chugh R; Karikari NK; Kim JI Biochem Biophys Res Commun; 2013 Apr; 434(1):137-42. PubMed ID: 23541585 [TBL] [Abstract][Full Text] [Related]
2. Phosphoprotein inhibitor CPI-17 specificity depends on allosteric regulation of protein phosphatase-1 by regulatory subunits. Eto M; Kitazawa T; Brautigan DL Proc Natl Acad Sci U S A; 2004 Jun; 101(24):8888-93. PubMed ID: 15184667 [TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of the myosin phosphatase inhibitors, CPI-17 and PHI-1, by integrin-linked kinase. Deng JT; Sutherland C; Brautigan DL; Eto M; Walsh MP Biochem J; 2002 Oct; 367(Pt 2):517-24. PubMed ID: 12144526 [TBL] [Abstract][Full Text] [Related]
4. Histamine-induced vasoconstriction involves phosphorylation of a specific inhibitor protein for myosin phosphatase by protein kinase C alpha and delta isoforms. Eto M; Kitazawa T; Yazawa M; Mukai H; Ono Y; Brautigan DL J Biol Chem; 2001 Aug; 276(31):29072-8. PubMed ID: 11397799 [TBL] [Abstract][Full Text] [Related]
5. Agonists trigger G protein-mediated activation of the CPI-17 inhibitor phosphoprotein of myosin light chain phosphatase to enhance vascular smooth muscle contractility. Kitazawa T; Eto M; Woodsome TP; Brautigan DL J Biol Chem; 2000 Apr; 275(14):9897-900. PubMed ID: 10744661 [TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of the myosin phosphatase targeting subunit and CPI-17 during Ca2+ sensitization in rabbit smooth muscle. Kitazawa T; Eto M; Woodsome TP; Khalequzzaman M J Physiol; 2003 Feb; 546(Pt 3):879-89. PubMed ID: 12563012 [TBL] [Abstract][Full Text] [Related]
8. The Evolution of Duplicated Genes of the Cpi-17/Phi-1 ( Lang I; Virk G; Zheng DC; Young J; Nguyen MJ; Amiri R; Fong M; Arata A; Chadaideh KS; Walsh S; Weiser DC Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32784920 [TBL] [Abstract][Full Text] [Related]
9. Expression of CPI-17 and myosin phosphatase correlates with Ca(2+) sensitivity of protein kinase C-induced contraction in rabbit smooth muscle. Woodsome TP; Eto M; Everett A; Brautigan DL; Kitazawa T J Physiol; 2001 Sep; 535(Pt 2):553-64. PubMed ID: 11533144 [TBL] [Abstract][Full Text] [Related]
10. Solution NMR structure of the myosin phosphatase inhibitor protein CPI-17 shows phosphorylation-induced conformational changes responsible for activation. Ohki S; Eto M; Kariya E; Hayano T; Hayashi Y; Yazawa M; Brautigan D; Kainosho M J Mol Biol; 2001 Dec; 314(4):839-49. PubMed ID: 11734001 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of myosin/moesin phosphatase by expression of the phosphoinhibitor protein CPI-17 alters microfilament organization and retards cell spreading. Eto M; Wong L; Yazawa M; Brautigan DL Cell Motil Cytoskeleton; 2000 Jul; 46(3):222-34. PubMed ID: 10913968 [TBL] [Abstract][Full Text] [Related]
12. Reciprocal regulation controlling the expression of CPI-17, a specific inhibitor protein for the myosin light chain phosphatase in vascular smooth muscle cells. Kim JI; Urban M; Young GD; Eto M Am J Physiol Cell Physiol; 2012 Jul; 303(1):C58-68. PubMed ID: 22538237 [TBL] [Abstract][Full Text] [Related]
13. Protein kinase C-catalyzed phosphorylation of an inhibitory phosphoprotein of myosin phosphatase is involved in human platelet secretion. Watanabe Y; Ito M; Kataoka Y; Wada H; Koyama M; Feng J; Shiku H; Nishikawa M Blood; 2001 Jun; 97(12):3798-805. PubMed ID: 11389019 [TBL] [Abstract][Full Text] [Related]
14. Phosphorylation of CPI-17, an inhibitor of myosin phosphatase, by protein kinase N. Hamaguchi T; Ito M; Feng J; Seko T; Koyama M; Machida H; Takase K; Amano M; Kaibuchi K; Hartshorne DJ; Nakano T Biochem Biophys Res Commun; 2000 Aug; 274(3):825-30. PubMed ID: 10924361 [TBL] [Abstract][Full Text] [Related]
15. Distinctive solution conformation of phosphatase inhibitor CPI-17 substituted with aspartate at the phosphorylation-site threonine residue. Ohki Sy; Eto M; Shimizu M; Takada R; Brautigan DL; Kainosho M J Mol Biol; 2003 Mar; 326(5):1539-47. PubMed ID: 12595264 [TBL] [Abstract][Full Text] [Related]
17. cAMP/PKA antagonizes thrombin-induced inactivation of endothelial myosin light chain phosphatase: role of CPI-17. Aslam M; Härtel FV; Arshad M; Gündüz D; Abdallah Y; Sauer H; Piper HM; Noll T Cardiovasc Res; 2010 Jul; 87(2):375-84. PubMed ID: 20202976 [TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of CPI-17, an inhibitory phosphoprotein of smooth muscle myosin phosphatase, by Rho-kinase. Koyama M; Ito M; Feng J; Seko T; Shiraki K; Takase K; Hartshorne DJ; Nakano T FEBS Lett; 2000 Jun; 475(3):197-200. PubMed ID: 10869555 [TBL] [Abstract][Full Text] [Related]
19. Novel in vitro and in vivo phosphorylation sites on protein phosphatase 1 inhibitor CPI-17. Dubois T; Howell S; Zemlickova E; Learmonth M; Cronshaw A; Aitken A Biochem Biophys Res Commun; 2003 Mar; 302(2):186-92. PubMed ID: 12604330 [TBL] [Abstract][Full Text] [Related]
20. Regulation of cellular protein phosphatase-1 (PP1) by phosphorylation of the CPI-17 family, C-kinase-activated PP1 inhibitors. Eto M J Biol Chem; 2009 Dec; 284(51):35273-7. PubMed ID: 19846560 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]